Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase
- PMID:25461250
- DOI: 10.1016/j.exphem.2014.11.001
Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase
Abstract
Drug resistance remains a serious problem in leukemia therapy. Among newly developed nucleoside antimetabolites, clofarabine has broad cytotoxic activity showing therapeutic promise and is currently approved for relapsed acute lymphoblastic leukemia. To investigate the mechanisms responsible for clofarabine resistance, we established two clofarabine-resistant lymphoblastic leukemia cell lines from parental lines. To elucidate the mechanisms against clofarabine resistance in two newly established clofarabine-resistant cell lines, we measured the expression of export pumps multidrug resistance protein 1, multidrug resistance-associated protein 1, and ATP-binding cassette subfamily G member 2. There were no differences in the expression between clofarabine-sensitive and -resistant cell lines. Next, we determined expression of deoxycytidine kinase (dCK), which phosphorylates clofarabine to exert cytotoxicity, in clofarabine-sensitive and -resistant cells. Clofarabine-resistant cells showed significantly decreased expression of dCK RNA when compared with sensitive cells. To elucidate the mechanisms of decreased dCK expression in clofarabine-resistant cells, we analyzed the methylation status of CpG islands of the dCK promoter and found no differences in methylation status between clofarabine-sensitive and -resistant cells. Next, we measured the acetylation status of histone and found that total histone acetylation, and histone H3 and H4 acetylation on chromatin immunoprecipitation assay were significantly decreased in resistant cells. Melatonin is an indolamine that functions in the regulation of chronobiological rhythms to exert cytotoxic effects. We examined the effects of melatonin in clofarabine-resistant cells and found that melatonin treatment led to significantly increased cytotoxicity with clofarabine in resistant cells via increased acetylation. Melatonin may be a useful candidate for overcoming clofarabine resistance in two newly established clofarabine resistant leukemia cell lines.
Copyright © 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.
Similar articles
- Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.Yoshida K, Fujita A, Narazaki H, Asano T, Itoh Y.Yoshida K, et al.Cancer Chemother Pharmacol. 2022 Jan;89(1):83-91. doi: 10.1007/s00280-021-04373-4. Epub 2021 Nov 26.Cancer Chemother Pharmacol. 2022.PMID:34825941
- Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.Månsson E, Flordal E, Liliemark J, Spasokoukotskaja T, Elford H, Lagercrantz S, Eriksson S, Albertioni F.Månsson E, et al.Biochem Pharmacol. 2003 Jan 15;65(2):237-47. doi: 10.1016/s0006-2952(02)01484-3.Biochem Pharmacol. 2003.PMID:12504799
- Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.Nagai S, Takenaka K, Nachagari D, Rose C, Domoney K, Sun D, Sparreboom A, Schuetz JD.Nagai S, et al.Cancer Res. 2011 Mar 1;71(5):1781-91. doi: 10.1158/0008-5472.CAN-10-1919. Epub 2011 Jan 18.Cancer Res. 2011.PMID:21245102Free PMC article.
- Clofarabine and nelarabine: two new purine nucleoside analogs.Gandhi V, Plunkett W.Gandhi V, et al.Curr Opin Oncol. 2006 Nov;18(6):584-90. doi: 10.1097/01.cco.0000245326.65152.af.Curr Opin Oncol. 2006.PMID:16988579Review.
- Mechanisms of anti-cancer action and pharmacology of clofarabine.Zhenchuk A, Lotfi K, Juliusson G, Albertioni F.Zhenchuk A, et al.Biochem Pharmacol. 2009 Dec 1;78(11):1351-9. doi: 10.1016/j.bcp.2009.06.094. Epub 2009 Jul 1.Biochem Pharmacol. 2009.PMID:19576186Review.
Cited by
- Melatonin May Increase Anticancer Potential of Pleiotropic Drugs.Bojková B, Kubatka P, Qaradakhi T, Zulli A, Kajo K.Bojková B, et al.Int J Mol Sci. 2018 Dec 6;19(12):3910. doi: 10.3390/ijms19123910.Int J Mol Sci. 2018.PMID:30563247Free PMC article.Review.
- Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells.Liu S, Liang B, Jia H, Jiao Y, Pang Z, Huang Y.Liu S, et al.FEBS Open Bio. 2017 Apr 27;7(6):798-810. doi: 10.1002/2211-5463.12223. eCollection 2017 Jun.FEBS Open Bio. 2017.PMID:28593135Free PMC article.
- Melatonin: does it have utility in the treatment of haematological neoplasms?Li T, Yang Z, Jiang S, Di W, Ma Z, Hu W, Chen F, Reiter RJ, Yang Y.Li T, et al.Br J Pharmacol. 2018 Aug;175(16):3251-3262. doi: 10.1111/bph.13966. Epub 2017 Sep 9.Br J Pharmacol. 2018.PMID:28880375Free PMC article.Review.
- Effects of miR-34b/miR-892a Upregulation and Inhibition of ABCB1/ABCB4 on Melatonin-Induced Apoptosis in VCR-Resistant Oral Cancer Cells.Hsieh MJ, Lin CW, Su SC, Reiter RJ, Chen AW, Chen MK, Yang SF.Hsieh MJ, et al.Mol Ther Nucleic Acids. 2020 Mar 6;19:877-889. doi: 10.1016/j.omtn.2019.12.022. Epub 2020 Jan 9.Mol Ther Nucleic Acids. 2020.PMID:31982774Free PMC article.
- Melatonin Attenuates Potato Late Blight by Disrupting Cell Growth, Stress Tolerance, Fungicide Susceptibility and Homeostasis of Gene Expression inPhytophthora infestans.Zhang S, Zheng X, Reiter RJ, Feng S, Wang Y, Liu S, Jin L, Li Z, Datla R, Ren M.Zhang S, et al.Front Plant Sci. 2017 Nov 21;8:1993. doi: 10.3389/fpls.2017.01993. eCollection 2017.Front Plant Sci. 2017.PMID:29209352Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Research Materials